|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Treatment |
| Conditions: |
Abscesses Furunculosis Staphylococcus Aureus Infection Staphylococcal Skin Infections |
| Interventions: |
Drug: Mupirocin ointment Genetic: Chlorhexidine showers Procedure: Bleach baths (dilute) Behavioral: Intensive education on personal hygiene |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| Hygiene Education | Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as "control group") |
| Hygiene Education + Mupirocin | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days |
| Education + Mupirocin + Chlorhexidine | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days. |
| Education + Mupirocin + Bleach Baths | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes). |
| Hygiene Education | Hygiene Education + Mupirocin | Education + Mupirocin + Chlorhexidine | Education + Mupirocin + Bleach Baths | |
|---|---|---|---|---|
| STARTED | 75 | 75 | 75 | 75 |
| COMPLETED | 64 | 62 | 64 | 54 |
| NOT COMPLETED | 11 | 13 | 11 | 21 |
| Hygiene Education | Hygiene Education + Mupirocin | Education + Mupirocin + Chlorhexidine | Education + Mupirocin + Bleach Baths | |
|---|---|---|---|---|
| STARTED | 64 | 62 | 64 | 54 |
| COMPLETED | 64 | 57 | 57 | 51 |
| NOT COMPLETED | 0 | 5 | 7 | 3 |
Baseline Characteristics
| Description | |
|---|---|
| Hygiene Education | Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as "control group") |
| Hygiene Education + Mupirocin | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days |
| Education + Mupirocin + Chlorhexidine | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days. |
| Education + Mupirocin + Bleach Baths | Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes). |
| Hygiene Education | Hygiene Education + Mupirocin | Education + Mupirocin + Chlorhexidine | Education + Mupirocin + Bleach Baths | Total | |
|---|---|---|---|---|---|
|
Number of Participants
[units: participants] |
75 | 75 | 75 | 75 | 300 |
|
Age
[units: years] Mean ± Standard Deviation |
17.37 ± 16.57 | 16.52 ± 16.12 | 18.19 ± 17.37 | 18.67 ± 15.29 | 17.61 ± 16.31 |
|
Gender
[units: participants] |
|||||
| Female | 34 | 37 | 52 | 38 | 161 |
| Male | 41 | 38 | 23 | 37 | 139 |
Outcome Measures
| 1. Primary: | Number of Participants Eradicated of S. Aureus Carriage - 1 Month After Intervention [ Time Frame: 1 month follow-up ] |
| 2. Secondary: | Number of Participants With Recurrent Staphylococcus Aureus Skin or Soft Tissue Infection [ Time Frame: 1, 4 and 6 month follow-ups ] |
| 3. Secondary: | Number of Participants Eradicated of S. Aureus Carriage - 4 Months After Intervention [ Time Frame: 4 month follow-up ] |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Bernard Camins, MD, Washington University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00513799 History of Changes |
| Other Study ID Numbers: | 9000C4 |
| Study First Received: | August 8, 2007 |
| Results First Received: | March 2, 2011 |
| Last Updated: | March 31, 2011 |
| Health Authority: | United States: Institutional Review Board |